Loading stock data…
AHCO
$13.17+0.06 (+0.46%)
Market ClosedLast close May 1
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AdaptHealth Corp. in the Healthcare sector is trading at $13.17. The stock is currently near its 52-week high of $13.40, remaining 31.6% above its 200-day moving average. Technical signals show neutral RSI of 65 and bearish MACD signal, explaining why AHCO maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 65) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.17
Potential Upside
5%
Whystock Fair Value$13.83
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus8 analysts
Buy
Mean target$13.19+0.1%
Range$9.50 – $17.00
Fundamentals
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.73B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.31%
Volume
Today's trading volume
1.13M
Recent News
3 Reasons to Sell AHCO and 1 Stock to Buy Instead
AdaptHealth has had an impressive run over the past six months as its shares have beaten the S&P 500 by 31.4%. The stock now trades at $12.50, marking a 36.8% gain. This performance may have investors wondering how to approach the situation.
Auna S.A.'s Oncology Initiatives Continue to Gain Traction in Mexico
AUNA advances oncology push in Mexico with new Oncocenter, insurer tie-ups, and rising revenues, signaling strong traction in a key growth market.
Reinhart Partners Loads Up on $20 Million Worth of AdaptHealth Shares
AdaptHealth delivers home medical equipment and chronic care solutions through a recurring-revenue model.
A Look At AdaptHealth (AHCO) Valuation After New US$1.1b Credit Facility And Rating Upgrades
AdaptHealth (AHCO) has just reshaped its balance sheet with a new US$1.1b senior secured credit facility. The company has extended debt maturities, lowered borrowing costs, and expanded liquidity to support its home medical equipment business. See our latest analysis for AdaptHealth. The refinancing news lands after a strong run in the shares, with a 30 day share price return of 16.28% and a year to date gain of 27.40%. The 1 year total shareholder return of 49.88% contrasts with a weaker 5...
AdaptHealth Refinances Senior Secured Credit Facility
AdaptHealth (AHCO) said Monday that it has closed a $1.1 billion senior secured credit facility, com